Dihydropteridine reductase deficiency: Physical structure the QDPR gene, identification two new mutations and genotype-phenotype correlations

Irma Dianzani, Luisa De Sanctis, Peter M. Smooker, Tamara J. Gough, Caria Alliaudi, Alfredo Brusco, Marco Spada, Nenad Blau, Marion Dobos, Hong Ping Zhang, Nan Yang, Alberto Ponzone, Wilfred L F Armarego, Richard G H Cotton

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Dihydropteridine reductase (DHPR) is an enzyme involved in recycling of tetrahydrobiopterin (BH4), the cofactor of the aromatic amino acid hydroxylases. Its deficiency is characterized by hyperphenylalaninemia due to the secondary defect of phenylalanine hydroxylase and depletion of the neurotransmitters dopamine and serotonin, whose syntheses are controlled by tryptophan and tyrosine hydroxylases. The DHPR cDNA has been cloned and mapped on 4p15.3. In the present study we report the genomic structure of the DHPR gene (QDPR). This gene includes seven exons within a range of 84-564 bp; the corresponding introns are flanked by canonic splice junctions. We also present a panel of PCR primers complementary to intronic sequences that greatly facilitates amplification of the gene and provides a genomic DNA approach for mutation detection. We have used this approach to study six patients with DHPR deficiency. Four known mutations (G23D, H158Y, IVS5G+ 1A, R221x) and two new mutations (Y150C and G2181ns9bp) were found. The Y150C mutation was found in compound heterozygosity with G23D, a mutation always associated with a severe phenotype in homozygous patients. This patient has an intermediate phenotype (good response to monotherapy with BH4). The mutant enzyme for Y150C was expressed in an E. coli system. Comparison of its kinetic parameters with those of the G23D mutant enzyme showed that it is not as effective as the wild-type enzyme, but is more active than the G23D mutant. This patient's intermediate phenotype is thus due to the mild DHPR mutation Y150C. Correlations between genotypes and phenotypes were also found for the other mutations.

Original languageEnglish
Pages (from-to)267-273
Number of pages7
JournalHuman Mutation
Volume12
Issue number4
DOIs
Publication statusPublished - 1998

Fingerprint

Phenylketonurias
Genetic Association Studies
Dihydropteridine Reductase
Mutation
Genes
Enzymes
Phenotype
Phenylalanine Hydroxylase
Tryptophan Hydroxylase
Aromatic Amino Acids
Gene Amplification
Tyrosine 3-Monooxygenase
Recycling
Mixed Function Oxygenases
Introns
Neurotransmitter Agents
Exons
Dopamine
Serotonin
Complementary DNA

Keywords

  • Dihydropteridine reductase
  • Genotype/phenotype correlation
  • Hyperphenylalaninemia
  • Tetrahydrobiopterin deficiency

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Dihydropteridine reductase deficiency : Physical structure the QDPR gene, identification two new mutations and genotype-phenotype correlations. / Dianzani, Irma; De Sanctis, Luisa; Smooker, Peter M.; Gough, Tamara J.; Alliaudi, Caria; Brusco, Alfredo; Spada, Marco; Blau, Nenad; Dobos, Marion; Zhang, Hong Ping; Yang, Nan; Ponzone, Alberto; Armarego, Wilfred L F; Cotton, Richard G H.

In: Human Mutation, Vol. 12, No. 4, 1998, p. 267-273.

Research output: Contribution to journalArticle

Dianzani, I, De Sanctis, L, Smooker, PM, Gough, TJ, Alliaudi, C, Brusco, A, Spada, M, Blau, N, Dobos, M, Zhang, HP, Yang, N, Ponzone, A, Armarego, WLF & Cotton, RGH 1998, 'Dihydropteridine reductase deficiency: Physical structure the QDPR gene, identification two new mutations and genotype-phenotype correlations', Human Mutation, vol. 12, no. 4, pp. 267-273. https://doi.org/10.1002/(SICI)1098-1004(1998)12:4<267::AID-HUMU8>3.0.CO;2-C
Dianzani, Irma ; De Sanctis, Luisa ; Smooker, Peter M. ; Gough, Tamara J. ; Alliaudi, Caria ; Brusco, Alfredo ; Spada, Marco ; Blau, Nenad ; Dobos, Marion ; Zhang, Hong Ping ; Yang, Nan ; Ponzone, Alberto ; Armarego, Wilfred L F ; Cotton, Richard G H. / Dihydropteridine reductase deficiency : Physical structure the QDPR gene, identification two new mutations and genotype-phenotype correlations. In: Human Mutation. 1998 ; Vol. 12, No. 4. pp. 267-273.
@article{6ddf26c74fc24a6fab89907fd41efc3d,
title = "Dihydropteridine reductase deficiency: Physical structure the QDPR gene, identification two new mutations and genotype-phenotype correlations",
abstract = "Dihydropteridine reductase (DHPR) is an enzyme involved in recycling of tetrahydrobiopterin (BH4), the cofactor of the aromatic amino acid hydroxylases. Its deficiency is characterized by hyperphenylalaninemia due to the secondary defect of phenylalanine hydroxylase and depletion of the neurotransmitters dopamine and serotonin, whose syntheses are controlled by tryptophan and tyrosine hydroxylases. The DHPR cDNA has been cloned and mapped on 4p15.3. In the present study we report the genomic structure of the DHPR gene (QDPR). This gene includes seven exons within a range of 84-564 bp; the corresponding introns are flanked by canonic splice junctions. We also present a panel of PCR primers complementary to intronic sequences that greatly facilitates amplification of the gene and provides a genomic DNA approach for mutation detection. We have used this approach to study six patients with DHPR deficiency. Four known mutations (G23D, H158Y, IVS5G+ 1A, R221x) and two new mutations (Y150C and G2181ns9bp) were found. The Y150C mutation was found in compound heterozygosity with G23D, a mutation always associated with a severe phenotype in homozygous patients. This patient has an intermediate phenotype (good response to monotherapy with BH4). The mutant enzyme for Y150C was expressed in an E. coli system. Comparison of its kinetic parameters with those of the G23D mutant enzyme showed that it is not as effective as the wild-type enzyme, but is more active than the G23D mutant. This patient's intermediate phenotype is thus due to the mild DHPR mutation Y150C. Correlations between genotypes and phenotypes were also found for the other mutations.",
keywords = "Dihydropteridine reductase, Genotype/phenotype correlation, Hyperphenylalaninemia, Tetrahydrobiopterin deficiency",
author = "Irma Dianzani and {De Sanctis}, Luisa and Smooker, {Peter M.} and Gough, {Tamara J.} and Caria Alliaudi and Alfredo Brusco and Marco Spada and Nenad Blau and Marion Dobos and Zhang, {Hong Ping} and Nan Yang and Alberto Ponzone and Armarego, {Wilfred L F} and Cotton, {Richard G H}",
year = "1998",
doi = "10.1002/(SICI)1098-1004(1998)12:4<267::AID-HUMU8>3.0.CO;2-C",
language = "English",
volume = "12",
pages = "267--273",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Dihydropteridine reductase deficiency

T2 - Physical structure the QDPR gene, identification two new mutations and genotype-phenotype correlations

AU - Dianzani, Irma

AU - De Sanctis, Luisa

AU - Smooker, Peter M.

AU - Gough, Tamara J.

AU - Alliaudi, Caria

AU - Brusco, Alfredo

AU - Spada, Marco

AU - Blau, Nenad

AU - Dobos, Marion

AU - Zhang, Hong Ping

AU - Yang, Nan

AU - Ponzone, Alberto

AU - Armarego, Wilfred L F

AU - Cotton, Richard G H

PY - 1998

Y1 - 1998

N2 - Dihydropteridine reductase (DHPR) is an enzyme involved in recycling of tetrahydrobiopterin (BH4), the cofactor of the aromatic amino acid hydroxylases. Its deficiency is characterized by hyperphenylalaninemia due to the secondary defect of phenylalanine hydroxylase and depletion of the neurotransmitters dopamine and serotonin, whose syntheses are controlled by tryptophan and tyrosine hydroxylases. The DHPR cDNA has been cloned and mapped on 4p15.3. In the present study we report the genomic structure of the DHPR gene (QDPR). This gene includes seven exons within a range of 84-564 bp; the corresponding introns are flanked by canonic splice junctions. We also present a panel of PCR primers complementary to intronic sequences that greatly facilitates amplification of the gene and provides a genomic DNA approach for mutation detection. We have used this approach to study six patients with DHPR deficiency. Four known mutations (G23D, H158Y, IVS5G+ 1A, R221x) and two new mutations (Y150C and G2181ns9bp) were found. The Y150C mutation was found in compound heterozygosity with G23D, a mutation always associated with a severe phenotype in homozygous patients. This patient has an intermediate phenotype (good response to monotherapy with BH4). The mutant enzyme for Y150C was expressed in an E. coli system. Comparison of its kinetic parameters with those of the G23D mutant enzyme showed that it is not as effective as the wild-type enzyme, but is more active than the G23D mutant. This patient's intermediate phenotype is thus due to the mild DHPR mutation Y150C. Correlations between genotypes and phenotypes were also found for the other mutations.

AB - Dihydropteridine reductase (DHPR) is an enzyme involved in recycling of tetrahydrobiopterin (BH4), the cofactor of the aromatic amino acid hydroxylases. Its deficiency is characterized by hyperphenylalaninemia due to the secondary defect of phenylalanine hydroxylase and depletion of the neurotransmitters dopamine and serotonin, whose syntheses are controlled by tryptophan and tyrosine hydroxylases. The DHPR cDNA has been cloned and mapped on 4p15.3. In the present study we report the genomic structure of the DHPR gene (QDPR). This gene includes seven exons within a range of 84-564 bp; the corresponding introns are flanked by canonic splice junctions. We also present a panel of PCR primers complementary to intronic sequences that greatly facilitates amplification of the gene and provides a genomic DNA approach for mutation detection. We have used this approach to study six patients with DHPR deficiency. Four known mutations (G23D, H158Y, IVS5G+ 1A, R221x) and two new mutations (Y150C and G2181ns9bp) were found. The Y150C mutation was found in compound heterozygosity with G23D, a mutation always associated with a severe phenotype in homozygous patients. This patient has an intermediate phenotype (good response to monotherapy with BH4). The mutant enzyme for Y150C was expressed in an E. coli system. Comparison of its kinetic parameters with those of the G23D mutant enzyme showed that it is not as effective as the wild-type enzyme, but is more active than the G23D mutant. This patient's intermediate phenotype is thus due to the mild DHPR mutation Y150C. Correlations between genotypes and phenotypes were also found for the other mutations.

KW - Dihydropteridine reductase

KW - Genotype/phenotype correlation

KW - Hyperphenylalaninemia

KW - Tetrahydrobiopterin deficiency

UR - http://www.scopus.com/inward/record.url?scp=7344244334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7344244334&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-1004(1998)12:4<267::AID-HUMU8>3.0.CO;2-C

DO - 10.1002/(SICI)1098-1004(1998)12:4<267::AID-HUMU8>3.0.CO;2-C

M3 - Article

C2 - 9744478

AN - SCOPUS:7344244334

VL - 12

SP - 267

EP - 273

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 4

ER -